medigraphic.com
ISSN 1405-8790 (Print)

2012, Number 2

<< Back

Rev Mex Med Fis Rehab 2012; 24 (2)

Prevalence of Cardiovascular Autonomic Neuropathy in patients with Type 2 Diabetes Mellitus and the standardization in the Mexican population using heart rate variability (HRV)

Gutiérrez FÁJ, Montes CML, Jiménez OJH

Language: Spanish
References: 61
Page: 45-55
PDF size: 395.48 Kb.


ABSTRACT

Objectives: The aim of this article was to standardize the normal parameters of heart rate variability in 100 healthy subjects, and then determine the frequency of Cardiovascular Autonomic Neuropathy in patients with type 2 diabetes mellitus. Material and methods: A cross section analytical study carried out in two stages: first stage: standardize the test for the heart rate variability in 100 healthy subjects between 40 and 85 years of age according to 3 of 5 test of Ewing’s methodology; second stage: using 41 patients with type 2 diabetes mellitus between 40 and 85 years of age; EMG machine was used for assessing the heart rate variability (HRV) with time analysis to perform the following three tests: 1. deep breathing, 2. standing up, 3. Valsalva maneuver. Analytical statistics were used and it was estimated by T Student that with independent samples and the Pearson coefficient, a correlation was established. Results: One hundred healthy subjects were taken in order to obtain accurate values for reference; 41 subjects who were diagnosed with type 2 diabetes mellitus were thus evaluated. In patients with type 2 DM, more than 60% demonstrated cardiovascular autonomic neuropathy; 41.4% showed autonomic dysfunction and 19.4% showed defined neuropathy. Conclusions: The standardization of heart rate variability (HRV) in the Mexican population as to determine the frequency of cardiovascular autonomic neuropathy, is greater than what had been previously established in international publications.


REFERENCES

  1. Expert Committee on the Diagnosis and Classification of Diabetes Diabetes Care 2006; 29 (Suppl. 1): S43-S48.

  2. Jermendy G. Clinical consequences of cardiovascular autonomic neuropathy in diabetic patients. Acta Diabetologica 2003; 40: S370.

  3. Curtis MB, O’Keefe JH Jr. Autonomic tone as a cardiovascular risk factor: the dangers of chronic fight or flight. Mayo Clin Proc 2002.

  4. Perkins, Bruce A, Bril Vera. Early vascular risk factor modification in type 1 diabetes. The New England Journal of Medicine 2005; 352(4): 408-409.

  5. Freeman R. Autonomic peripheral neuropathy. The Lancet 2005; 365, 9466, 1259.

  6. Spallone V, Menzinger G. Diagnosis of cardiovascular autonomic neuropathy in diabetes. Diabetes 1997; 46.

  7. Vinik IA, Maser ER, Mitchell DB. Roy freeman diabetic autonomic neuropathy. Diabetes Care 2003; 26(5): 1553.

  8. Quirantes HA, López GL, Curbelo SV, Montano LJA, Machado LP, Quirantes MA. La calidad de vida del paciente diabético. Rev Cubana Med Gen Integ 2000; 16(1): 50-6.

  9. Vinik IA, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation 2007; 115: 387-397.

  10. Ziegler D, Sohr GHC, Nourooz-Zadeh J. Oxidative stress and antioxidant defense in relation to the severity of diabetic polyneuropathy and cardiovascular autonomic neuropathy. Diabetes Care 2004; 27(9): 2178.

  11. Ziegler D, Gries FA, Muhlen H, Rathmann W, Spuler M, Lessmann F et al. Prevalence and clinical correlates of cardiovascular autonomic and peripheral diabetic neuropathy in patients attending diabetes centers. Diabetes Metab 1993; 19: 143-151.

  12. Maguire A, Craighead A, Craig M et al. Autonomic nerve testing predicts the development of complications: a 12-year follow up study. Diabetes Care 2007; 30: 1.

  13. Vinik A, Erbas T. Recognizing and treating diabetic autonomic neuropathy Cleveland. Clinic Journal of Medicine 2001; 68(11).

  14. Gerritsen J, Dekker MJ, TenVoorde JB; Kostense JP et al. Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease. The Hoorn Study. Diabetes Care 2001; 24: 10.

  15. Moran A, Palmas W, Field L, Bhattarai J et al. Cardiovascular autonomic neuropathy is associated with microalbuminuria in older patients with type 2 diabetes. Diabetes Care 2004; 27(4): 972.

  16. Hauerslev FC, Vestbo E, Froland A, Gjessing HJ et al. Autonomic neuropathy in non diabetic offspring of type 2 diabetic subjects is associated with urinary albumin excretion rate and 24-h ambulatory blood pressure. Diabetes 2001; 50: 3.

  17. Bruna AJ, Navarro X. Neuropatía autonómica en la diabetes mellitus. Rev Neurol 2005; 40(2): 102-110.

  18. Cameron EN, Cotter AM. Metabolic and vascular factors in the pathogenesis of diabetic neuropathy. Diabetes 1997; 46(S2): 31-37.

  19. Erewster WJ. Diabetic neuropathy, nerve growth factor and other neurotrophic factors. TINS 1994; 7(8): 321-24.

  20. Anand P. Neurotrophic factors and their receptors in human sensory neuropathies. Prog Brain Res 2004; 146: 477-492.

  21. Pittenger G, Vinik A. Nerve growth factor and diabetic neuropathy. Exp Diabetic Res 2003; 4(4): 271-85.

  22. Hilsted J. Pathophysiology in diabetic autonomic neuropathy. Cardiovascular, hormonal, and metabolic studies. Diabetes 1982; 31: 730.

  23. Leinninger GM, Vincent AM, Feldman EL. The role of growth factors in diabetic peripheral neuropathy. J Peripher Nerv Syst 2004; 9(1): 26-53.

  24. Pfeifer M, Feldman E. Diabetic autonomic neuropathy, 2004. In: The diabetes mellitus. Manual 6th Edition. Ed. New York, McGraw Hill, 2004; 351.

  25. Vita G, Princi P, Messina C. Multivariate analysis of cardiovascular reflexes applied to the diagnosis of autonomic neuropathy. Journal of Neurology 1991; 238(5).

  26. Kaye JM, Corrall RJ, Lightman SL. A new test for autonomic cardiovascular and neuroendocrine responses in diabetes mellitus: evidence for early vagal dysfunction. Diabetologia 2005; 48: 180-186.

  27. Ziegler D. Diabetic autonomic neuropathy cardiac sympathetic “dysinnervation” QT interval prolongation, and mortality. Clin Auton Res 2002; 12: 349-352.

  28. Colberg SR, Swain D, Vinik IA. Use of heart rate reserve and rating of perceived exertion to prescribe exercise intensity in diabetic autonomic neuropathy. Diabetes Care 2003; 26: 986-990.

  29. Parati G. Cardiovascular variability analysis. An insight into the pathophysiology of cardiovascular disease and the impact of treatment. With caution. Clin Auton Res 2002; 12: 4-8.

  30. Langer A, Freeman M, Josse R, Steiner G et al. Am J Cardiol 1991; 67: 1073-1078.

  31. Raelene EM, Braxton DM, Aaron IV et al. The association between cardiovascular autonomic neuropathy and mortality in Individual with diabetes a meta analysis. Diabetes Care 2003; 26(6): 1895.

  32. Lahrmann H, Magnifico F, Haensch A et al Autonomic nervous system laboratories: a European survey. European Journal of Neurology 2005; 12: 375-379.

  33. Boulton M, Arezzo CV et al. A statement by the American Diabetes Association. Diabetes Care 2005; 28: 956-962.

  34. Chessa M, Butera G, Lanza GA et al. Role of heart rate variability in the early diagnosis of diabetic autonomic neuropathy in children Herz Urban & Vogel. 2002; 785.

  35. American Diabetes Association. Report and recommendations of the San Antonio Conference on the diabetic neuropathy. Muscle and Nerve 1988; 661-667.

  36. Ewing DJ, Clarke BF. Diagnosis and management of diabetic autonomic neuropathy. Br Med J 1982; 285: 916-918.

  37. Sztajzel J. Heart rate variability: a noninvasive electrocardiographic Method to measure the autonomic nervous system. Swiss Med Wkly 2004; 134: 514-522.

  38. Risk M, Bril V, Broadbridge C et al. Heart Rate variability measurement in diabetic neuropathy: review of methods diabetes technology & therapeutics. 2001; 3(1): 63-76.

  39. Radespiel-Tröger M, Rauh R, Mahlke C et al. Agreement of two different methods for measurement of heart rate variability. Clin Auton Res 2003; 13: 99-102.

  40. Ryder REJ, Hardisty CA. Which battery of cardiovascular autonomic function tests? Diabetologia 1990; 33: 177-179.

  41. Frattola A, Parati G, Gamba P et al. Time and frequency domain estimates of spontaneous baroreflex sensitivity provide early detection of autonomic dysfunction in diabetes mellitus. Diabetologia 1997; 40: 1470-1475.

  42. Lishner M, Akselrod S, Avi VM, Oz O, Divon M, Ravid M. Spectral analysis of heart rate fluctuations. A noninvasive, sensitive method for the early diagnosis of autonomic neuropathy in diabetes mellitus. J Auton Nerv Syst 1987; 19: 119-125.

  43. Gert van Dijk J. Heart rate variability testing, or listening to a conversation in a foreign language. Clin Auton Res 2003; 13: 304-305.

  44. Makimattila S, Schlenzka A, Mantysaari M, Bergholm R et al. Predictors of abnormal cardiovascular autonomic function measured by frequency Domain Analysis of heart variability and conventional test in patients with type 1 diabetes. Diabetes Care 2000; 23: 11-1686.

  45. Pagani M, Malfatto G, Pierini S et al. Spectral analysis of heart rate variability in the assessment of autonomic diabetic neuropathy. J Auton Nerv Syst 1988; 23: 143-153.

  46. García J, Serrano A, del Castillo S et al. Predictores de muerte súbita en la enfermedad coronaria. Rev Esp Cardiol 2000; 53: 440-462.

  47. Van Ravenswaaij-Arts, Conny MA, Louis AK et al. Heart rate variability review annals of internal medicine. 1993; 118(6): 436-447.

  48. Low v. Clinical autonomic disorders. Evaluation and Management 2a Edition Editorial Lippincott-Raven 1997. In: Vinik A, Park T, Stansberry K, Pittenger G. Diabetic neuropathies: Diabetologia 2000; 43: 957-973.

  49. Meter D. Drummond the effect of pain on changes in heart rate during the Valsalva manoeuvre. Clin Auton Res 2003; 13: 316-320.

  50. Claus D, Meudt O, Rozeik C et al. Prospective investigation of autonomic cardiac neuropathy in diabetes mellitus. Clin Auton Res 2002; 12: 373-378.

  51. Mateika HJ, DeMeersman ER, Kim J. Effects of lung volume and chemoreceptor activity on blood pressure and R-R interval during the Valsalva maneuver. Clin Auton Res 2002; 12: 24-34.

  52. Vita G, Princi P, Messina C. Multivariate analysis of cardiovascular reflexes applied to the diagnosis of autonomic neuropathy. Journal of Neurology 1991; 238.

  53. Eckberg DL, Harkins SW, Frisch JM, Musgrave GE, Gadner DF. Baroreflex control of plasma norepinephrine and heart rate period in healthy subjects and diabetic patients. J Clin Invest 1986; 78: 366-374.

  54. Gulli G, Fattor B, Marchesi M. Cross-spectral analysis of cardiovascular variables in supine diabetic patients. Clin Auton Res 2005; 15: 92-98.

  55. Hilstead J, Parving HH, Christensen NJ, Benn J, Galbo H. Hemodynamics in diabetic orthostatic hypotension. J Clin Invest 1981; 68: 1427-1434.

  56. Zhang Y, Critchley LA, Tam YH, Tomlinson B. Short-term postural reflexes in diabetic patients with autonomic dysfunction. Diabetologia 2004; 47: 304-311.

  57. Pfeifer MA, Peterson H. Cardiovascular autonomic neuropathy. In: Dyck PJ, Thomas PK, Asbury AK, Winegrad AI, Porte AD, eds. Diabetic neuropathy. Philadelphia: WB Saunders, 1987: 122-33.

  58. Jacob G, Costa F, Biaggioni I. Spectrum of autonomic cardiovascular neuropathy in diabetes. Diabetes Care 2003; 26(7): 2174.

  59. Krivickas L. Electrodiagnosis in neuromuscular disorders. Saunders Company 2003: 287-310.

  60. Huggett RJ, Scott EM, Gilbey SG, Bannister J. Disparity of autonomic control in type 2 diabetes mellitus. Diabetologia 2005; 48: 172-179.

  61. Tamošiūnaitė M, Urbonavičienė G, Vainoras A et al. Influence of deep breathing on heart rate variability in patients with ischemic heart disease elektronika ir elektrotechnika. 2005: 3(59).




2020     |     www.medigraphic.com